OBSEVA SA (OBSV)

CH0346177709 - Common Stock

0.1018  -0.02 (-15.52%)

After market: 0.0826 -0.02 (-18.86%)

News Image
9 days ago - ObsEva SA

ObsEva Announces Update on Board of Directors

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
a month ago - ObsEva SA

ObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 28 February 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
2 months ago - ObsEva SA

Geneva Court Grants Temporary Moratorium to ObsEva

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 31 January 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
4 months ago - ObsEva SA

ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – November 30, 2023 – ObsEva SA (SIX: OBSN), a...

News Image
5 months ago - ObsEva SA

Organon Returns Ebopiprant to XOMA

News Image
5 months ago - ObsEva SA

Organon Returns Ebopiprant to XOMA

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   Geneva, Switzerland – October 27, 2023 – ObsEva SA (SIX: OBSN), a...

News Image
6 months ago - ObsEva SA

ObsEva Files half Year 2023 Financial Statements

ObsEva Files half Year 2023 Financial Statements Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – September...

News Image
9 months ago - ObsEva SA

ObsEva Recovers Full Worldwide Rights on Nolasiban

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July 13, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
9 months ago - ObsEva SA

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023 Annual General Meeting held on June 29, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 30, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
10 months ago - ObsEva SA

Annual General Meeting 2023

News Image
10 months ago - ObsEva SA

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
a year ago - ObsEva SA

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – May 2, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
a year ago - ObsEva SA

ObsEva Annual Report 2022

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – April 28, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...

News Image
a year ago - ObsEva SA

ObsEva Announces Change of Central Securities Depositary

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 20, 2023 – ObsEva SA (SIX: OBSN / OTC Pink Market:...

News Image
a year ago - ObsEva SA

ObsEva Files Year End 2022 Financial Statements

ObsEva Files Year End 2022 Financial Statements Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 31,...

News Image
a year ago - ObsEva SA

ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a...

News Image
a year ago - ObsEva SA

ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a...

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news!

News Image
a year ago - InvestorPlace

Why Is Lucira Health (LHDX) Stock Down 14% Today?

Lucira Health (LHDX) stock is falling on Friday after the company's shares have seen extreme volatility throughout the week.

News Image
a year ago - InvestorPlace

Why Is Veru (VERU) Stock Down 37% Today?

Veru (VERU) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment.

News Image
a year ago - InvestorPlace

Why Is Hub Cyber Security (HUBC) Stock Up 62% Today?

Hub Cyber Security (HUBC) stock is on the rise shortly after the company went public via a SPAC merger with Mount Rainier Acquisition Corp.